Journal of Clinical Endocrinology & Metabolism, Vol 79, 1122-1127, Copyright © 1994 by Endocrine Society

ARTICLES

Pituitary size assessed with magnetic resonance imaging as a measure of growth hormone secretion in long term survivors of childhood cancer

KK Talvensaari, M Lanning, E Paakko, P Tapanainen and M Knip
Department of Pediatrics, University of Oulu, Finland.

We investigated 37 long term survivors of childhood cancer to study the relationship among growth, GH secretion, and pituitary size. The median follow-up time after diagnosis was 13.2 yr. The pituitary gland was visualized with magnetic resonance imaging. Radiated patients (n = 25) had a reduced relative height and showed a greater reduction in relative height after diagnosis than nonradiated patients (n = 12). The patients had lower spontaneous nocturnal GH secretion than controls due to a reduced peak amplitude. Spontaneous GH secretion was lower in radiated patients than in nonradiated subjects. The patients had lower plasma insulin-like growth factor-I (IGF-I) and serum IGF-binding protein-3 (IGFBP-3) concentrations than the controls. Radiated subjects had decreased IGF-I and IGFBP-3 concentrations compared to nonradiated subjects. Half of the patients (20 of 37) evaluated with magnetic resonance imaging had a reduced pituitary size (pituitary height, < -2 SD score). Radiated subjects had smaller pituitary glands than nonradiated ones. Seventeen of 20 patients (85%) with reduced pituitary size had decreased nocturnal GH release. There was a positive correlation between nocturnal GH secretion, plasma IGF-I, and serum IGFBP-3 levels, on the one hand, and pituitary height, on the other. These results indicate that cranial radiation may result in tissue damage, leading to decreased pituitary size, reduced spontaneous GH secretion, and impaired linear growth. The finding of reduced IGF-I levels in both radiated and nonradiated patients combined with decreased IGFBP-3 concentrations in radiated patients, indicates that cytotoxic chemotherapy may induce hepatic damage resulting in decreased IGF-I synthesis.

This article has been cited by other articles:

				K. Kananen, L. Volin, K. Laitinen, H. Alfthan, T. Ruutu, and M. J. Valimaki Prevention of Bone Loss after Allogeneic Stem Cell Transplantation by Calcium, Vitamin D, and Sex Hormone Replacement with or without Pamidronate J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3877 - 3885. [Abstract] [Full Text] [PDF]

				L. Adan, C. Trivin, C. Sainte-Rose, J. M. Zucker, O. Hartmann, and R. Brauner GH Deficiency Caused by Cranial Irradiation during Childhood: Factors and Markers in Young Adults J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5245 - 5251. [Abstract] [Full Text] [PDF]

				P. Arikoski, J. Komulainen, P. Riikonen, J. S Jurvelin, R. Voutilainen, and H. Kröger Reduced bone density at completion of chemotherapy for a malignancy Arch. Dis. Child., February 1, 1999; 80(2): 143 - 148. [Abstract] [Full Text]